Cargando…
A functional inflammasome activation assay discriminates between genetically proven caps patients and patients with low penetrance NLRP3 variants
Autores principales: | Rieber, Nikolaus, Gavrilov, Alina, Endres, Theresa, Hartl, Dominik, Kümmerle-Deschner, Jasmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184308/ http://dx.doi.org/10.1186/1546-0096-12-S1-P74 |
Ejemplares similares
-
A functional inflammasome activation assaydifferentiates patients with pathogenic NLRP3mutations and symptomatic patients with lowpenetrance variants
por: Rieber, N, et al.
Publicado: (2015) -
A refractory heterogeneous Cryopyrin-Associated Periodic Syndrome (CAPS) phenotype related to V198M mutation responds to canakinumab - a case report
por: Hansmann, Sandra, et al.
Publicado: (2011) -
PW02-040 - Low-penetrance NLRP3 variants
por: Endres, T, et al.
Publicado: (2013) -
PReS-FINAL-2331: Low-penetrance NLRP3 variants
por: Endres, T, et al.
Publicado: (2013) -
PW02-042 - Induction of MDSC in Muckle-Wells syndrome
por: Rieber, N, et al.
Publicado: (2013)